WEDNESDAY, Jan. 29, 2025 (HealthDay News) — “Hidden hunger” — low levels of essential vitamins or minerals — is common among people with type 2 diabetes, a new evidence review says Overall, as many as 45% of type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and electrolytes, researchersContinue Reading
TUESDAY, Jan. 28, 2025 (HealthDay News) — Helping kids with obesity drop pounds can have a huge impact on their future health. When these children and teens lose weight, they are less likely to have type 2 diabetes, high blood pressure and elevated cholesterol as young adults, researchers reported inContinue Reading
TUESDAY, Jan. 28, 2025 (HealthDay News) — Major heart health risk factors like obesity, diabetes and high blood pressure remain on the rise in the United States, according to an annual report from the American Heart Association (AHA). These risks are thwarting efforts to save lives from heart disease, heartContinue Reading
FRIDAY, Jan. 24, 2025 (HealthDay News) — People can reverse their type 2 diabetes through a combination of calorie cutting and medication, a small clinical trial says. Overweight and obese adults caused their diabetes to go into remission by following a calorie-restricted diet and taking the prescription diabetes drug dapagliflozin,Continue Reading
TUESDAY, Jan. 21, 2025 (HealthDay News) — Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia. But these drugs also come with risks that shouldn’t be overlooked, researchers warn in a study publishedContinue Reading
FRIDAY, Jan. 10, 2025 (HealthDay News) — Munching on carrots may help benefit your health, especially if you live with type 2 diabetes. At least, that is the hope of researchers in Denmark. “We see carrots as a potential component of future dietary strategies for type 2 diabetes,” says LarsContinue Reading
WEDNESDAY, Jan. 8, (HealthDay News) — Sugar-sweetened drink consumption accounts for more than 2 million new cases of type 2 diabetes, and 1.2 million new cases of heart disease worldwide annually. According to new research published Jan. 6 in the journal Nature Medicine, people all over the world are impactedContinue Reading
WEDNESDAY, Jan. 8, 2025 (HealthDay News) — Preventing diabetes can be as good for a person’s wallet as it is for their health, a new study says. People participating in a diabetes prevention program saved more than $5,000 in direct medical costs over two years, researchers reported recently in theContinue Reading
THURSDAY, Jan. 2, 2024 (HealthDay News) — Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds. These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways toContinue Reading
TUESDAY, Dec. 10, 2024 (HealthDay News) — People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds. The study found that folks with diabetes who were using the drugsContinue Reading
THURSDAY, Dec. 5, 2024 (HealthDay News) — The choice may be bittersweet, but the evidence is clear: New research shows that dark chocolate can lower a person’s risk of type 2 diabetes. People who ate at least five servings of dark chocolate a week had a 21% lower risk ofContinue Reading
WEDNESDAY, Dec. 4, 2024 (HealthDay News) — Taking even high doses of supplementary vitamin D won’t lower an older person’s odds for type 2 diabetes, new research confirms. Vitamin D supplements may have other benefits, but in otherwise healthy folks with sufficient levels of the nutrient, “our findings do notContinue Reading
WEDNESDAY, Nov. 27, 2024 (HealthDay News) — The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced the risk of diabetes in obese prediabetic patients by more than 90% during a three-year period compared to placebo, trial resultsContinue Reading
WEDNESDAY, Nov. 27, 2024 (HealthDay News) — Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients have it as well, new research shows. Metformin appears to help boost the benefits of immunotherapy drugs used to fight lung tumors,Continue Reading